Besides the MAPK pathway, TNFα-Tpl2 mediated pathways could be additional therapeutic targets for developing anti-tumor agents since TNFα-mediated COX2 expression plays an important role in inflammation and carcinogenesis. This evidence concerns the gene MAP3K8 and neoplasm.